Daclatasvir/Asunaprevir/Beclabuvir (DCV-TRIO), All-Oral, Fixed-Dose Combination for Patients With Chronic HCV Genotype 1.
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Ming-Lung Yu Vasily Isakov Jia-Horng Kao Sang Hoon Ahn |
| Publication date | March 31, 2017 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |